Phase 1/2a Clinical Trial in ALS with Ropinirole, a Drug Candidate Identified by Ipsc Drug Discovery
Cell stem cell(2023)
Key words
amyotrophic lateral sclerosis,ALS,ropinirole hydrochloride,dopamine D2 receptor agonist,iPSC drug discovery,translational research,phase 1/2a trial,PRO-ACT registry data,reverse translational research,cholesterol synthesis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined